Board of Director
Owen Hughes is the CEO of Cullinan Oncology, a portfolio company of MPM’s crossover investment strategy, which is focused on developing high-value cancer therapeutics using a cost-efficient business model. Prior to MPM, Owen served as the Chief Business Officer and Head of Corporate Development at Intarcia Therapeutics, where he was responsible for financing, M&A, business development and operations.
Prior to Intarcia, he served as a Director of Brookside Capital, a hedge fund under the Bain Capital umbrella, managing public and private healthcare investments.
Prior to his tenure at Brookside, Owen was Senior Portfolio Manager at Pyramis Global Advisors, a Fidelity Investments Company. He has more than 16 years of Wall Street experience, on both the buy- and sell-side. Owen is currently a director of Radius Health and Translate Bio. Owen received his B.A. from Dartmouth College.
